Skip to main content
eScholarship
Open Access Publications from the University of California

Scholarly Works (3 results)

  • Article
  • Peer Reviewed
Nutrition Bytes, Volume 10, Issue 2 (2005)

Coronary heart disease (CHD) continues to be the leading cause of death in the United States today. As research continues to implicate increased levels of serum low-density lipoprotein cholesterol (LDL-C) as a major cause of CHD, many therapies have been designed to specifically lower LDL-C, in hopes of preventing CHD. In 2001, the National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP III) recommended that first line therapy for primary prevention of CHD should involve dietary and behavioral modifications, otherwise referred to as therapeutic lifestyle changes (TLC). In order to evaluate both primary and secondary prevention strategies, currently available options are described below, including dietary modifications, pharmacotherapy, and high-density lipoprotein cholesterol (HDL-C) therapies. Finally, critical evaluation of recent studies provides further support for the guidelines established by the NCEP ATP III, which strongly recommends therapeutic lifestyle changes (TLC) as first-line therapy for primary prevention of CHD.

  • 1 supplemental file
Cover page: Dietary Portfolio, Exercise, and Pharmaceuticals: A Review of Current Cholesterol-Lowering Therapies
  • Article
  • Peer Reviewed
UCLA Previously Published Works (2009)
We present a case of Strongyloides stercoralis hyperinfection in a 30-year-old HIV positive female who presents with diffuse alveolar hemorrhage. We discuss the relevant differential diagnoses and characteristic imaging findings.
    Cover page: 30-Year-old HIV-positive Female With Diffuse Alveolar Hemorrhage
    • Article
    • Peer Reviewed
    UC San Francisco Previously Published Works (2015)
    BACKGROUND: Right adrenal vein (RAV) catheterization can be a very challenging step in adrenal venous sampling (AVS). Visualization of the inferior emissary vein (IEV) may be an indication of successful RAV catheterization. PURPOSE: To compare the rate of successful RAV sampling in the presence of the IEV. MATERIAL AND METHODS: Retrospective review of all consecutive patients with PA who underwent AVS between April 2009 and April 2012 was performed. A total of 30 patients were identified. Procedural images, cortisol, and aldosterone values obtained from sampling of the RAV and inferior vena cava (IVC) were reviewed. Cortisol measurements obtained from RAV samples were divided by measurements from the infra-renal IVC blood samples in order to calculate the selectivity index (SI). An SI >3 was considered indicative of technically successful RAV sampling. RESULTS: RAV sampling was considered technically successful in 29 out of 30 cases (97%). In cases of successful RAV sampling (29 patients), the IEV was identified in 25 patients (86%). The IEV was visualized in isolation in 16 patients (64%), and in conjunction with visualization of the RAV or right adrenal gland stain in nine patients (36%). The IEV was not visualized in the one case of unsuccessful RAV sampling. Visualizing the IEV had a sensitivity of 86.2% for successful RAV sampling. CONCLUSION: The IEV may serve as a reliable landmark for the RAV during RAV sampling.
      Cover page: The inferior emissary vein: a reliable landmark for right adrenal vein sampling
      Top